Sources

17 Total Sources

Vertex Buys Crinetics for $10 Billion, Adding $85-a-Share Rare Endocrine Drug Portfolio

Left40%

Center50%

Right10%

The Boston Globe10d ago

Vertex Pharmaceuticals Acquires Crinetics for $10 Billion, Boosting Rare Endocrine Disorder Portfolio

Bloomberg10d ago

Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion, Expanding Endocrinology Portfolio

Vertex to buy Crinetics for $10 billion in rare-diseases push | Reuters

Vertex to buy Crinetics in an all-cash deal valued at $10 billion

StockTitan10d ago

Vertex to Buy Crinetics for $10B in Cash | CRNX Stock News

BioPharma Dive10d ago

Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion

Yahoo Finance10d ago

CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition

intellectia.ai10d ago

Vertex Acquires Crinetics for $10 Billion in Cash Deal | Intellectia.AI

Pulse 2.010d ago

Vertex Acquiring Crinetics Pharmaceuticals For $10 Billion

The Wall Street Journal10d ago

Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion - WSJ

Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion for Rare Hormonal Disease Treatments

Marketscreener.com10d ago

Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion | MarketScreener

Yahoo Canada Finance10d ago

Vertex to buy Crinetics for $10 billion to expand rare-disease business

Vertex to Acquire Crinetics Pharmaceuticals in $10 Billion Deal | citybiz

VRTX x $CRNX $XBI BREAKING: Vertex Pharmaceuticals Inc. agreed to buy Crinetics Pharmaceuticals Inc. for $10 billion in cash to expand into endocrinology, including medicines for acromegaly and hormone disorders. > The

TipRanks10d ago

M&A News: Vertex Stock (VRTX) Slips After Announcing the $10B Crinetics Acquisition - TipRanks.com

Букви10d ago

Vertex announces deal to buy Crinetics for 10 billion dollars and gain Palsonify | Ukraine news - #Mezha